![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|20|2|253-261
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.20, Iss.2, 2014-01, pp. : 253-261
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Oo C.Y. Akbari B. Lee S. Nichols G. Hellmann C.P.
Clinical Drug Investigation, Vol. 17, Iss. 3, 1999-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ghrelin as a Potential Anti-Obesity Target
Current Pharmaceutical Design, Vol. 9, Iss. 17, 2003-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
α-Lipoic acid, an anti-obesity agent?
Expert Opinion on Investigational Drugs, Vol. 13, Iss. 12, 2004-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current Bioactive Compounds, Vol. 2, Iss. 4, 2006-12 ,pp. :